datamatters24/research-document-archive huggingface dataset:
108TH CONGRESS
1ST SESSION
H. CON. RES. 142
CONCURRENT RESOLUTION
Whereas on Monday, April 7, 2003, the Syracuse University
Orangemen men’s basketball team won its first Division
I national basketball championship;
Whereas Syracuse University won the championship game by
defeating the University of Kansas Jayhawks 81–78;
Whereas the Syracuse University team was led by freshman
Carmelo Anthony, who was voted the Most Outstanding
•HCON 142 EH
Player of the Final Four, and received outstanding effort
and support from Gerry McNamara, Billy Edelin, Kueth
Duany, Hakim Warrick, Craig Forth, Jeremy McNeil,
and Josh Pace;
Whereas the roster of the Syracuse University team also in-
cluded Tyrone Albright, Josh Brooks, Xzavier Gaines,
Matt Gorman, Gary Hall, Ronneil Herron, and Andrew
Kouwe;
Whereas Head Coach Jim Boeheim has coached at Syracuse
University for 27 years and been involved with the Syra-
cuse University men’s basketball team for more than half
his life;
Whereas Coach Boeheim had previously coached in two na-
tional championship games, including a heartbreaking
loss in 1987;
Whereas Coach Boeheim and his coaching staff, including As-
sociate Head Coach Bernie Fine and Assistant Head
Coaches Mike Hopkins and Troy Weaver, deserve much
credit for the outstanding determination and accomplish-
ments of their young team; and
Whereas the students, alumni, faculty, and supporters of Syr-
acuse University are to be congratulated for their com-
mitment and pride in their national champion men’s bas-
ketball team: Now, therefore, be it
Resolved by the House of Representatives (the Senate
concurring), That the Congress—
(1) congratulates the Syracuse University men’s
basketball team for winning the 2003 NCAA Divi-
sion I men’s basketball national championship;
•HCON 142 EH
(2) recognizes the achievements of all the
team’s players, coaches, and support staff and in-
vites them to the United States Capitol Building to
be honored;
(3) requests that the President recognize the
achievements of the Syracuse University men’s bas-
ketball team and invite them to the White House for
an appropriate ceremony honoring a national cham-
pionship team; and
(4) directs the Clerk of the House of Represent-
atives to make available enrolled copies of this reso-
lution to Syracuse University for appropriate display
and to transmit an enrolled copy of this resolution
to each coach and member of the 2003 NCAA Divi-
sion I men’s basketball national championship team.
Passed the House of Representatives April 9, 2003.
Attest:
Clerk.
108TH CONGRESS
1ST SESSION
H. CON. RES. 142
CONCURRENT RESOLUTION
Congratulating the Syracuse University men’s bas-
ketball team for winning the 2003 NCAA Divi-
sion I men’s basketball national championship.
IV 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 142
Congratulating the Syracuse University men’s basketball team for winning 
the 2003 NCAA Division I men’s basketball national championship. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 8, 2003
Mr. WALSH (for himself, Mr. QUINN, Mr. BOEHLERT, Mr. MCHUGH, and Mr. 
HINCHEY) submitted the following concurrent resolution; which was re-
ferred to the Committee on Education and the Workforce 
CONCURRENT RESOLUTION 
Congratulating the Syracuse University men’s basketball 
team for winning the 2003 NCAA Division I men’s bas-
ketball national championship.
Whereas on Monday, April 7, 2003, the Syracuse University 
Orangemen men’s basketball team won its first Division 
I national basketball championship; 
Whereas Syracuse University won the championship game by 
defeating the University of Kansas Jayhawks 81–78; 
Whereas the Syracuse University team was led by freshman 
Carmelo Anthony, who was voted the Most Outstanding 
Player of the Final Four, and received outstanding effort 
and support from Gerry McNamara, Billy Edelin, Kueth 
Duany, Hakim Warrick, Craig Forth, Jeremy McNeil, 
and Josh Pace;
•HCON 142 IH 
Whereas the roster of the Syracuse University team also in-
cluded Tyrone Albright, Josh Brooks, Xzavier Gaines, 
Matt Gorman, Gary Hall, Ronneil Herron, and Andrew 
Kouwe; 
Whereas Head Coach Jim Boeheim has coached at Syracuse 
University for 27 years and been involved with the Syra-
cuse University men’s basketball team for more than half 
his life; 
Whereas Coach Boeheim had previously coached in two na-
tional championship games, including a heartbreaking 
loss in 1987; 
Whereas Coach Boeheim and his coaching staff, including As-
sociate Head Coach Bernie Fine and Assistant Head 
Coaches Mike Hopkins and Troy Weaver, deserve much 
credit for the outstanding determination and accomplish-
ments of their young team; and 
Whereas the students, alumni, faculty, and supporters of Syr-
acuse University are to be congratulated for their com-
mitment and pride in their national champion men’s bas-
ketball team : Now, therefore, be it
Resolved by the House of Representatives (the Senate 
concurring), That the Congress—
(1) congratulates the Syracuse University men’s 
basketball team for winning the 2003 NCAA Divi-
sion I men’s basketball national championship; 
(2) recognizes the achievements of all the 
team’s players, coaches, and support staff and in-
vites them to the United States Capitol Building to 
be honored;
•HCON 142 IH 
(3) requests that the President recognize the 
achievements of the Syracuse University men’s bas-
ketball team and invite them to the White House for 
an appropriate ceremony honoring a national cham-
pionship team; and 
(4) directs the Clerk of the House of Represent-
atives to make available enrolled copies of this reso-
lution to Syracuse University for appropriate display 
and to transmit an enrolled copy of this resolution 
to each coach and member of the 2003 NCAA Divi-
sion I men’s basketball national championship team.
Æ
III 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 142
IN THE SENATE OF THE UNITED STATES 
APRIL 10, 2003
Received and referred to the Committee on the Judiciary 
CONCURRENT RESOLUTION 
Congratulating the Syracuse University men’s basketball 
team for winning the 2003 NCAA Division I men’s bas-
ketball national championship.
Whereas on Monday, April 7, 2003, the Syracuse University 
Orangemen men’s basketball team won its first Division 
I national basketball championship; 
Whereas Syracuse University won the championship game by 
defeating the University of Kansas Jayhawks 81–78; 
Whereas the Syracuse University team was led by freshman 
Carmelo Anthony, who was voted the Most Outstanding
HCON 142 RFS 
Player of the Final Four, and received outstanding effort 
and support from Gerry McNamara, Billy Edelin, Kueth 
Duany, Hakim Warrick, Craig Forth, Jeremy McNeil, 
and Josh Pace; 
Whereas the roster of the Syracuse University team also in-
cluded Tyrone Albright, Josh Brooks, Xzavier Gaines, 
Matt Gorman, Gary Hall, Ronneil Herron, and Andrew 
Kouwe; 
Whereas Head Coach Jim Boeheim has coached at Syracuse 
University for 27 years and been involved with the Syra-
cuse University men’s basketball team for more than half 
his life; 
Whereas Coach Boeheim had previously coached in two na-
tional championship games, including a heartbreaking 
loss in 1987; 
Whereas Coach Boeheim and his coaching staff, including As-
sociate Head Coach Bernie Fine and Assistant Head 
Coaches Mike Hopkins and Troy Weaver, deserve much 
credit for the outstanding determination and accomplish-
ments of their young team; and 
Whereas the students, alumni, faculty, and supporters of Syr-
acuse University are to be congratulated for their com-
mitment and pride in their national champion men’s bas-
ketball team: Now, therefore, be it
Resolved by the House of Representatives (the Senate 
concurring), That the Congress—
(1) congratulates the Syracuse University men’s 
basketball team for winning the 2003 NCAA Divi-
sion I men’s basketball national championship;
HCON 142 RFS 
(2) recognizes the achievements of all the 
team’s players, coaches, and support staff and in-
vites them to the United States Capitol Building to 
be honored; 
(3) requests that the President recognize the 
achievements of the Syracuse University men’s bas-
ketball team and invite them to the White House for 
an appropriate ceremony honoring a national cham-
pionship team; and 
(4) directs the Clerk of the House of Represent-
atives to make available enrolled copies of this reso-
lution to Syracuse University for appropriate display 
and to transmit an enrolled copy of this resolution 
to each coach and member of the 2003 NCAA Divi-
sion I men’s basketball national championship team.
Passed the House of Representatives April 9, 2003. 
Attest: 
JEFF TRANDAHL, 
Clerk.
•HCON 144 EH
Whereas Dinah Washington was hired to sing with Lionel
Hampton’s big band in 1943, and through this exposure
gained her first recording contract;
Whereas Dinah Washington was recording with jazz stars
and leaders in the industry by 1948, and was a full-
fledged pop music star by the late 1950s after recording
the ballad, ‘‘What a Difference a Day Makes’’;
Whereas Dinah Washington recorded in jazz, blues, rhythm
and blues, and pop, and was considered a preeminent fig-
ure and enormously gifted vocalist in each; and
Whereas Dinah Washington died on December 14, 1963,
after dominating the charts in the late 1940s and 1950s,
and by today’s measures would have been considered a
tremendous crossover superstar: Now, therefore, be it
Resolved by the House of Representatives (the Senate
concurring), That it is the sense of Congress that Dinah
Washington should be recognized for her versatility, re-
markable musical talent, and for influence on female vo-
calists in jazz, blues, rhythm and blues, pop, and gospel.
Passed the House of Representatives July 12, 2004.
Attest:
Clerk.
IV 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 144
Expressing the sense of Congress that Dinah Washington should be recognized 
for her achievements as one of the most talented vocalists in American 
popular music history. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 9, 2003
Mr. RANGEL submitted the following concurrent resolution; which was referred 
to the Committee on Education and the Workforce 
CONCURRENT RESOLUTION 
Expressing the sense of Congress that Dinah Washington 
should be recognized for her achievements as one of 
the most talented vocalists in American popular music 
history.
Whereas Dinah Washington was born in August 1924; 
Whereas Dinah Washington was a singer and performer 
whose early influence and focus was gospel music and 
spirituals, and who first toured the Nation to perform in 
1940; 
Whereas Dinah Washington was hired to sing with Lionel 
Hampton’s big band in 1943, and through this exposure 
gained her first recording contract; 
Whereas Dinah Washington was recording with jazz stars 
and leaders in the industry by 1948, and was a full-
•HCON 144 IH 
fledged pop music star by the late 1950s after recording 
the ballad, ‘‘What a Difference a Day Makes’’; 
Whereas Dinah Washington recorded in jazz, blues, rhythm 
and blues, and pop, and was considered a preeminent fig-
ure and enormously gifted vocalist in each; and 
Whereas Dinah Washington died on December 14, 1963, 
after dominating the charts in the late 1940s and 1950s, 
and by today’s measures would have been considered a 
tremendous crossover superstar: Now, therefore, be it
Resolved by the House of Representatives (the Senate 
concurring), That it is the sense of Congress that Dinah 
Washington should be recognized for her versatility, re-
markable musical talent, and for influence on female vo-
calists in jazz, blues, rhythm and blues, pop, and gospel.
Æ
III 
108TH CONGRESS 
2D SESSION 
H. CON. RES. 144 
IN THE SENATE OF THE UNITED STATES 
JULY 13, 2004 
Received and referred to the Committee on the Judiciary 
CONCURRENT RESOLUTION 
Expressing the sense of Congress that Dinah Washington 
should be recognized for her achievements as one of 
the most talented vocalists in American popular music 
history. 
Whereas Dinah Washington was born in August 1924; 
Whereas Dinah Washington was a singer and performer 
whose early influence and focus was gospel music and 
spirituals, and who first toured the Nation to perform in 
1940;
HCON 144 RFS 
Whereas Dinah Washington was hired to sing with Lionel 
Hampton’s big band in 1943, and through this exposure 
gained her first recording contract; 
Whereas Dinah Washington was recording with jazz stars 
and leaders in the industry by 1948, and was a full- 
fledged pop music star by the late 1950s after recording 
the ballad, ‘‘What a Difference a Day Makes’’; 
Whereas Dinah Washington recorded in jazz, blues, rhythm 
and blues, and pop, and was considered a preeminent fig-
ure and enormously gifted vocalist in each; and 
Whereas Dinah Washington died on December 14, 1963, 
after dominating the charts in the late 1940s and 1950s, 
and by today’s measures would have been considered a 
tremendous crossover superstar: Now, therefore, be it 
Resolved by the House of Representatives (the Senate 
concurring), That it is the sense of Congress that Dinah 
Washington should be recognized for her versatility, re-
markable musical talent, and for influence on female vo-
calists in jazz, blues, rhythm and blues, pop, and gospel. 
Passed the House of Representatives July 12, 2004. 
Attest: 
JEFF TRANDAHL, 
Clerk.
IV 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 145
Expressing the sense of the House of Representatives that Lena Horne 
should be recognized as one of the most popular performers of the 
1940s and 1950s and for her outspoken opposition to racial and social 
injustice. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 9, 2003
Mr. RANGEL submitted the following concurrent resolution; which was referred 
to the Committee on Government Reform 
CONCURRENT RESOLUTION 
Expressing the sense of the House of Representatives that 
Lena Horne should be recognized as one of the most 
popular performers of the 1940s and 1950s and for 
her outspoken opposition to racial and social injustice.
Whereas Lena Horne was born on June 30, 1917, in Brook-
lyn, New York; 
Whereas Lena Horne left school at the age of 14 and took 
her first stage job in order to help contribute to the fam-
ily during the Depression; 
Whereas Lena Horne began singing at Harlem’s famed Cot-
ton Club at age 16 and began performing on Broadway 
soon after;
•HCON 145 IH 
Whereas Lena Horne was 21 when she performed in her first 
feature role, ‘‘The Duke is Tops’’, after having taken a 
number of smaller roles that were often all that was 
available to blacks in Hollywood at the time; 
Whereas Lena Horne was eventually signed with MGM stu-
dios, making her the first African-American to be signed 
to a long-term film contract, only to find that she was 
edited out of films that were distributed in the South; 
Whereas Lena Horne performed in ‘‘Cabin in the Sky’’ in 
1943, which is often regarded as the premier perform-
ance of her career; and 
Whereas Lena Horne continues to represent elegance, Holly-
wood glamour, wisdom, and the strength and determina-
tion of an entire generation of performers who struggled 
through racism and prejudice during the height of their 
careers: Now, therefore, be it
Resolved by the House of Representatives (the Senate 
concurring), That it is the sense of Congress that Lena 
Horne should be recognized for her achievements as a 
singer and Hollywood actress, for her contributions to the 
struggles for equality, and for using her celebrity as a cat-
alyst for change.
Æ
108TH CONGRESS
1ST SESSION
H. CON. RES. 147
CONCURRENT RESOLUTION
Whereas Congress passed, and President Ronald Reagan
signed into law on January 4, 1983, the Orphan Drug
Act;
Whereas there are many diseases and conditions, such as
Huntington’s disease, myoclonus, ALS (Lou Gehrig’s dis-
ease), Tourette syndrome, and muscular dystrophy, that
affect such small numbers of individuals—populations
•HCON 147 EH
under 200,000—residing in the United States that the
diseases and conditions are considered rare;
Whereas there are 6,000 known rare diseases and conditions,
affecting approximately 25,000,000 Americans;
Whereas these rare diseases and conditions are sometimes re-
ferred to as ‘‘orphan’’ diseases and conditions, and drugs
(including biological products) to treat them are some-
times referred to as ‘‘orphan drugs’’;
Whereas, prior to 1983, because so few individuals were af-
fected by any one orphan disease or condition, a pharma-
ceutical company that developed an orphan drug may
have reasonably expected the drug to generate relatively
small sales in comparison to the cost of developing the
drug and, therefore, to incur a financial loss;
Whereas the object of the Orphan Drug Act was to stimulate
the development of orphan drugs;
Whereas the Orphan Drug Act is one of the most successful
Federal laws enacted in the last 20 years;
Whereas, prior to 1983, less than 40 therapies existed to
treat orphan diseases and conditions as compared today
to the more than 238 drugs, foods, and devices that now
exist to treat an estimated 11,000,000 patients in the
United States;
Whereas 85 percent of orphan drugs are being used to treat
serious or life-threatening diseases, 31 percent treat rare
forms of cancer, and approximately 50 percent are ap-
proved for pediatric uses;
Whereas the National Organization for Rare Disorders, es-
tablished in 1983, is a federation of voluntary health or-
ganizations dedicated to helping people with orphan dis-
•HCON 147 EH
eases and conditions and assisting the organizations that
serve them; and
Whereas the National Organization for Rare Disorders is
committed to the identification, treatment, and cure of
orphan diseases and conditions through programs of edu-
cation, advocacy, research, and service: Now, therefore,
be it
Resolved by the House of Representatives (the Senate
concurring), That the Congress celebrates the 20th anni-
versary of the Orphan Drug Act and the National Organi-
zation for Rare Disorders, and recognizes the great con-
tributions the Orphan Drug Act has made to the rare dis-
ease community.
Passed the House of Representatives May 19, 2003.
Attest:
Clerk.
IV 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 147
Commemorating the 20th Anniversary of the Orphan Drug Act and the 
National Organization for Rare Disorders. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 10, 2003
Mr. FOLEY (for himself, Mr. WAXMAN, Mr. SHIMKUS, Mr. BROWN of Ohio, 
Mr. KOLBE, Ms. SLAUGHTER, Mr. HERGER, Mr. MCNULTY, Mr. 
PALLONE, Mr. GREEN of Texas, Mr. ALLEN, Mrs. CAPPS, Mr. LAHOOD, 
and Mr. ENGEL) submitted the following concurrent resolution; which 
was referred to the Committee on Energy and Commerce 
CONCURRENT RESOLUTION 
Commemorating the 20th Anniversary of the Orphan Drug 
Act and the National Organization for Rare Disorders.
Whereas Congress passed, and President Ronald Regan 
signed into law on January 4, 1983, the Orphan Drug 
Act; 
Whereas there are many diseases and conditions, such as 
Huntington’s disease, myoclonus, ALS (Lou Gehrig’s dis-
ease), Tourette syndrome and muscular dystrophy, that 
affect such small numbers of individuals—populations 
under 200,000—residing in the United States that the 
diseases and conditions are considered rare; 
Whereas there are 6,000 known rare diseases and conditions, 
affecting approximately 25,000,000 Americans;
•HCON 147 IH 
Whereas these rare diseases and conditions are sometimes re-
ferred to as ‘‘orphan’’ diseases and conditions, and drugs 
(including biological products) to treat them are some-
times referred to as ‘‘orphan drugs’’; 
Whereas, prior to 1983, because so few individuals were af-
fected by any one orphan disease or condition, a pharma-
ceutical company that developed an orphan drug may 
have reasonably expected the drug to generate relatively 
small sales in comparison to the cost of developing the 
drug and, therefore, to incur a financial loss; 
Whereas the object of the Orphan Drug Act was to stimulate 
the development of orphan drugs, 
Whereas the Orphan Drug Act is one of the most successful 
Federal laws enacted in the last 20 years; 
Whereas, prior to 1983, less than 40 therapies existed to 
treat orphan diseases and conditions as compared today 
to the more than 238 drugs, foods, and devices that now 
exist to treat an estimated 11,000,000 patients in the 
United States; 
Whereas 85 percent of orphan drugs are being used to treat 
serious and/or life-threatening diseases, 31 percent treat 
rare forms of cancer, and approximately 50 percent are 
approved for pediatric uses; 
Whereas the National Organization of Rare Disorders, estab-
lished in 1983, is a federation of voluntary health organi-
zations dedicated to helping people with orphan diseases 
and conditions and assisting the organizations that serve 
them; and 
Whereas the National Organization of Rare Disorders is com-
mitted to the identification, treatment and cure of orphan
•HCON 147 IH 
diseases and conditions through programs of education, 
advocacy, research and service: Now, therefore, be it
Resolved by the House of Representatives (the Senate 
concurring), That the Congress celebrates the 20th Anni-
versary of the Orphan Drug Act and the National Organi-
zation of Rare Disorders, and recognizes the great con-
tributions the Orphan Drug Act has made to the rare dis-
ease community.
Æ
III 
108TH CONGRESS 
1ST SESSION 
H. CON. RES. 147
IN THE SENATE OF THE UNITED STATES 
MAY 20, 2003
Received and referred to the Committee on the Judiciary 
CONCURRENT RESOLUTION 
Commemorating the 20th anniversary of the Orphan Drug 
Act and the National Organization for Rare Disorders.
Whereas Congress passed, and President Ronald Reagan 
signed into law on January 4, 1983, the Orphan Drug 
Act; 
Whereas there are many diseases and conditions, such as 
Huntington’s disease, myoclonus, ALS (Lou Gehrig’s dis-
ease), Tourette syndrome, and muscular dystrophy, that 
affect such small numbers of individuals—populations
HCON 147 RFS 
under 200,000—residing in the United States that the 
diseases and conditions are considered rare;
Whereas there are 6,000 known rare diseases and conditions, 
affecting approximately 25,000,000 Americans; 
Whereas these rare diseases and conditions are sometimes re-
ferred to as ‘‘orphan’’ diseases and conditions, and drugs 
(including biological products) to treat them are some-
times referred to as ‘‘orphan drugs’’; 
Whereas, prior to 1983, because so few individuals were af-
fected by any one orphan disease or condition, a pharma-
ceutical company that developed an orphan drug may 
have reasonably expected the drug to generate relatively 
small sales in comparison to the cost of developing the 
drug and, therefore, to incur a financial loss; 
Whereas the object of the Orphan Drug Act was to stimulate 
the development of orphan drugs; 
Whereas the Orphan Drug Act is one of the most successful 
Federal laws enacted in the last 20 years; 
Whereas, prior to 1983, less than 40 therapies existed to 
treat orphan diseases and conditions as compared today 
to the more than 238 drugs, foods, and devices that now 
exist to treat an estimated 11,000,000 patients in the 
United States; 
Whereas 85 percent of orphan drugs are being used to treat 
serious or life-threatening diseases, 31 percent treat rare 
forms of cancer, and approximately 50 percent are ap-
proved for pediatric uses; 
Whereas the National Organization for Rare Disorders, es-
tablished in 1983, is a federation of voluntary health or-
ganizations dedicated to helping people with orphan dis-
HCON 147 RFS 
eases and conditions and assisting the organizations that 
serve them; and 
Whereas the National Organization for Rare Disorders is 
committed to the identification, treatment, and cure of 
orphan diseases and conditions through programs of edu-
cation, advocacy, research, and service: Now, therefore, 
be it
Resolved by the House of Representatives (the Senate 
concurring), That the Congress celebrates the 20th anni-
versary of the Orphan Drug Act and the National Organi-
zation for Rare Disorders, and recognizes the great con-
tributions the Orphan Drug Act has made to the rare dis-
ease community.
Passed the House of Representatives May 19, 2003. 
Attest: 
JEFF TRANDAHL, 
Clerk.